NP
NovaBay Pharmaceuticals Inc
🇺🇸XNYS.NBYUnited StatesHealthcare
$0.84USDdown -0.02 (-2.33%)ClosedEnd of day10:08 AM
Price$0.84-0.02 (-2.33%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US66987P2011
- CUSIP
- 66987P201
Company
- Employees
- 2
- Headquarters
- Emeryville, United States
- Website
- https://novabay.com
- CEO
- Mr. Michael Kazley
Market
- Shares outstanding
- 26.6M
- Market cap
- $22.37M
Highlights
- Market cap
- $22.37M
- EPS LTM
- $20.09
- P/E LTM
- 0.07
- Div yield
- 12.51%
Fundamentals (LTM)
- Revenue
- $2.46M-73.96%down year on year
- Net income
- $522.59M+14,174.57%up year on year
- Gross margin
- 98.46%+50.48%up year on year
- Free cash flow
- -$8.87M-51%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.